Holdings of Forefront Analytics, LLC
31 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 92.8 % of the equity sleeve
Sector breakdown
- Funds 9.9 %
- Health care 3.2 %
- Technology 2.8 %
- Financials 1.7 %
- Industrials 0.7 %
- Materials 0.5 %
- Consumer staples 0.3 %
- Unattributed 81.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 99.6 %
- KY 0.3 %
- GB 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 28 | 88M $ | 99.56 % |
| 2 | KY | 1 | 283.3K $ | 0.32 % |
| 3 | GB | 2 | 109K $ | 0.12 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | iShares ESG Aware MSCI EAFE ETF | 254,427 | 24.3M $ | |
| 2 | iShares ESG Aware MSCI EM ETF | 369,453 | 16.8M $ | |
| 3 | Vanguard International Equity Index Funds | 180,162 | 9.7M $ | |
| 4 | iShares Core High Dividend ETF | 68,087 | 9.2M $ | |
| 5 | Xtrackers MSCI EAFE Hedged Equ | 126,892 | 6.3M $ | |
| 6 | iShares MSCI USA Momentum Factor ETF | 24,234 | 5.8M $ | |
| 7 | Vanguard FTSE Developed Markets ETF | 47,307 | 3M $ | |
| 8 | iShares Core S&P 500 ETF | 4,474 | 2.9M $ | |
| 9 | NVIDIA Corp | 14,241 | 2.5M $ | |
| 10 | JPMorgan Chase & Co | 4,984 | 1.5M $ | |
| 11 | Deere & Co | 1,136 | 640.2K $ | |
| 12 | UnitedHealth Group Inc | 1,983 | 536.6K $ | |
| 13 | Edwards Lifesciences Corp | 6,574 | 526.4K $ | |
| 14 | Abbott Laboratories | 5,043 | 517.7K $ | |
| 15 | Schwab US Dividend Equity ETF | 15,119 | 463.9K $ | |
| 16 | ProShares Ultra S&P500 | 8,164 | 423.6K $ | |
| 17 | Incyte Corp | 4,233 | 398.4K $ | |
| 18 | Pfizer Inc | 13,090 | 367.6K $ | |
| 19 | Blue Owl Technology Finance Corp | 29,654 | 367.4K $ | |
| 20 | Regeneron Pharmaceuticals, Inc. | 460 | 355K $ | |
| 21 | Thermo Fisher Scientific Inc | 579 | 284.6K $ | |
| 22 | LEGEND BIOTECH CORP | 15,659 | 283.3K $ | |
| 23 | Vanguard Value ETF | 1,317 | 258.5K $ | |
| 24 | Danaher Corp | 1,288 | 244.2K $ | |
| 25 | Philip Morris International Inc. | 1,450 | 239.7K $ | |
| 26 | Nkarta Inc | 43,835 | 92.5K $ | |
| 27 | Geron Corp | 55,125 | 82.1K $ | |
| 28 | Annexon Inc | 14,240 | 78.9K $ | |
| 29 | Bicycle Therapeutics PLC | 14,394 | 66.8K $ | |
| 30 | CytomX Therapeutics Inc | 12,476 | 58.6K $ | |
| 31 | MEREO BIOPHARMA GROUP PLC | 127,778 | 42.2K $ | |